Ten-Year Outcomes after CAR T-Cell Therapy for B-Cell Lymphomas

Marco Ruella

Luca Paruzzo

Emeline R. Chong

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia

Elise A. Chong

Lymphoma Program, Abramson Cancer Center, Division of Hematology Oncology, Department of Medicine, University of Pennsylvania

Daniel J. Landsburg

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia

Sunita D. Nasta

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia

Pooja Devi

Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia

Peter Michener

Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia

Federico Stella

Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia

Alberto Carturan

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia

Ellen B. Napier

Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia

Vivianna M. Van Deerlin

Patrizia Porazzi

Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia

Bruce L. Levine

Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia

Noelle Frey

Department of Medicine, Division of Hematology–Oncology, Hospital of the University of Pennsylvania, Philadelphia

David L. Porter

Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia

Joseph A. Fraietta

Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania

Jakub Svoboda

Institute of Science and Technology Austria

Carl H. June

Stephen J. Schuster

Lymphoma Program, Abramson Cancer Center, Division of Hematology Oncology, Department of Medicine, University of Pennsylvania